DHA 20mg +Piperaq160mg disp. tab/3/PAC-2

General description:
Dihydroartemisinin 20mg + Piperaquine 160mg dispersible tablets in a blister of 3 tablets. Each pack contains 2 blisters accompanied by a patient information leaflet.

Technical specification:
Each dispersible tablet contains Dihydroartemisinin 20 mg (DHA) and Piperaquine tetraphosphate 160 mg

Therapeutic class:
Dihydroartemisinin is the active metabolite of artemisinin
Piperaquine is a 4-Aminoquinolone

Shelf life:
24 months

Storage instructions:
Do not store above 25°C

Dosage and instructions for use:
Guidelines for malaria